 Pharmaceuticals - Poland (Focus Analysis)
Value of the pharmaceutical market in Poland
/ OTC and Rx pharmaceuticals
/ Refunded pharmaceuticals
/ ATC groups
/ Imported
Table of contents List of tables / figures |
2008 |
290,00€ |
Global Antivirals Market Analysis & Forecasts 2008-2023
Antiviral drugs assessment and opportunities
/ Key industrial players in the global antivirals market
/ Forecasts of global anti
Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
The Global Vaccines Market 2008-2023
Sales forecasts for vaccines by disease area, brand and country, including novel therapeutic vaccines
/ Examination of strengths,
Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
Ad funded mobile content: Forecasts and Analysis 2008
Mobile content is evolving. What was previously expensive and difficult to obtain is now becoming accessible to a large section of
Table of contents Extract |
2008 |
3.000,00$ |
China Antibiotic Market Report, 2008-2009
From the perspective of industrial scale, China's output and production capacity of antibiotic raw materials ranks the NO.1 in the
Table of contents List of tables / figures |
2008 |
2.500,00$ |
Global Clinical Trial Business Report & Analysis 2008-2018
The global clinical trials business is worth an estimated $50bn in 2008, with a growth of rate of 10%. The market will show consid
Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
Osteoporosis & Bone Metabolism Disorders Market 2008-2023
In 2007, the world market for bone metabolism disorder pharmaceuticals generated sales of over $10bn - how much of this market hav
Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
Pfizer - Market Outlook for a Global Leader, 2008-2013
Visiongain believes that the period 2008 to 2013 will be pivotal for Pfizer, particularly due to patent expiry and the demands of
Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
The BRIC Telecoms Report -
Brazil, Russia, India and China are regarded as the four biggest emerging markets. Between the end of 2001 and the end of 2007, BR
Table of contents Extract |
2008 |
3.000,00$ |
Therapeutic Monoclonal Antibodies Report 2008-2023
This brand new report investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical industry as a
Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
Generics in Asia-Pacific
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in Belgium
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in Canada
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in China
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in Europe
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in France
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in Germany
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in Italy
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in Japan
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in Spain
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in the Netherlands
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in the United Kingdom
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Generics in the United States
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
Global Generics
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece
Table of contents List of tables / figures |
2008 |
250,00$ |
2008 Annual Research Report on China Pharmaceutical Raw Materials Mf Industry
The report combines the current status of Pharmaceutical Raw Materials Mf industry,special study,together with Pharmaceutical Ra
Table of contents |
2008 |
1.500,00$ |
